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Chronichypertensionleadstoconcomitantremodelingofthecardiacandvascularsystemsandvariousorgans,especiallythebrain,
kidney,andretina.Thebrainisanearlytargetoforgandamageduetohighbloodpressure,whichisthemajormodiﬁableriskfactor
forstrokeandsmallvesseldisease.Strokeisthesecondleadingcauseofdeathandthenumberonecauseofdisabilityworldwideand
over 80% ofstrokes occur in the elderly. Preclinical hypertensive lesionsin mosttarget organs are clearly identiﬁed: left ventricular
hypertrophy for the heart, microalbuminuria for the kidney, fundus abnormalities for the eye, and intima-media thickness and
pulse wave velocity for the vessels. However, early hypertensive brain damage is not fully studied due to diﬃculties in access and
the expense of techniques. After age, hypertension is the most-important risk factor for cerebral white matter lesions, which are
an important prognostic factor forstroke, cognitive impairment, dementia, and death. Studies have shownan associationbetween
white matter lesions and a number of extracranial systems aﬀected by high BP and also suggest that correct antihypertensive
treatment could slow white matter lesions progression. There is strong evidence that cerebral white matter lesions in hypertensive
patients should be considered a silent early marker of brain damage.
1.Introduction
Chronic hypertension leads to concomitant remodeling of
the cardiac and vascular systems, and various organs, espe-
cially the brain, kidney, and retina [1, 2]. Early detection of
hypertensive target organ damage is important for more-
successful prevention of cardiovascular diseases and to im-
prove outcomes [1, 2]. The brain is an early target for organ
damage due to high blood pressure (BP) [1, 2], which is
the major modiﬁable risk factor in men and women for
ischemic and hemorrhagic stroke [3], as well as small vessel
disease [1, 2, 4] predisposing to lacunar infarction, white
matter lesions (WML), and cerebral microbleeds, which are
frequently silent [1, 2, 5].
Stroke is the second leading cause of death and the lead-
ing cause of disability worldwide [6]. For each decade of life
after the age of 55 years, the stroke rate doubles in both
men and women, and >80% of strokes occur in people
aged ≥65 years [6]. Because of the aging population, the
burden of stroke will increase greatly in forthcoming years.
The increased vulnerability of elderly people to stroke is
associated with changes in the aging brain and also with a
higher prevalence of well-documented risk factors for stroke
such as hypertension, atrial ﬁbrillation, carotid stenosis, and
cardiovascular disease [3].
The clinical signiﬁcance and pathological substrate of
WML are incompletely understood. It is known that WMLs
are an important prognostic factor for stroke, cognitive
impairment, dementia and death [7]. Cerebral WML are
more common and extensive in patients with cardiovascular
risk factors, such as hypertension and diabetes mellitus,
heart disease, and symptomatic cerebrovascular disease [7–
10]. However, it is controversial whether BP still is asso-
ciated with WML in patients manifesting vascular disease.
Vlek et al. [11] showed in 1030 patients manifesting vas-
cular disease (including cerebrovascular disease, coronary2 Journal of Aging Research
heart disease, peripheral arterial disease, abdominal aortic
aneurysm), that BP was not associated with the presence of
WML, irrespective of the presence of diabetes mellitus or the
localisation of vascular disease.
Older age and hypertension are constantly reported to be
the main risk factors for cerebral WML [4, 10]. Hypertensive
patients have a higher rate and extension of cerebral WML
compared with normotensives [10, 12], but treated, con-
trolled hypertensive patients have a lower prevalence of
WML than both untreated and treated but uncontrolled
hypertensives [12]. A magnetic resonance imaging (MRI)
substudy of the randomized PROGRESS trial of BP lowering
with perindopril versus placebo in normotensive and hyper-
tensive subjects with cerebrovascular disease found that the
mean total volume of new WML was signiﬁcantly reduced
in the active treatment group compared with placebo [13].
A post hoc analysis found that greatest beneﬁcial eﬀect of
antihypertensive therapy on WML progression was observed
in patients with severe WML at study entry. Godin et al. [14]
have recently shown that, in a prospective population-based
cohort of 1319 subjects aged ≥65 years, BP at baseline and
changes in BP over a 4-year follow-up are strong predictors
ofWML volumeprogression independentlyofpotentialcon-
founders and suggest thatcorrect antihypertensive treatment
could slow WML progression. Interestingly, the Cardiovas-
cular Health Study [15] has been recently shown that dias-
tolic BP had no eﬀect on ischemic stroke incidence in elderly
patients with low WML levels but had a marginally signiﬁ-
cant J-curve relationship with ischemic stroke in elderly with
high WML levels. Indeed, in elderly individuals with low-
grade WML, low DBP may not pose a risk for ischemic
s t r o k e .H o w e v e r ,i nh i g h - g r a d eW M L ,i s c h e m i cs t r o k er i s k
may increase in diastolic BP less than 69mmHg but is
highest more than 80mmHg. The main current hypothesis
concerning the association between high BP and WML is
that long-standing hypertension causes lipohyalinosis of the
media and thickening of the vessel walls, with narrowing of
thelumenofthesmall perforating arteries and arterioles that
nourishthedeepwhitematter.Theperforatingvessels,which
originate in the cortical and leptomeningeal arteries, have a
relatively poor anastomotic system, which makes the white
matter particularly vulnerable to cerebral ischemia. Low BP
has also been reported to be a risk factor for WML [4].
Vuorinen etal. [16] showed in a 20-yearfollow-up study that
risk of late-life WML was related to midlife hypertension,
and hypertension from midlife to late life also increased the
risk of WML. In addition, an association with WML was
seen for decreasing BP (hypertension at midlife but not at
late life) even after controlling for antihypertensive treat-
ment. Authors speculate that the decline in BP could be
secondary to dementia-related processes, when structures
involvedin BPregulationbecomeaﬀected.Ithasbeenshown
in elderly people that severe WMLs frequently coexist with
medial temporal lobe and global brain atrophy [17].
There is strong evidence that cerebral WML in hyperten-
sive patients should be considered a silent early marker of
brain damage [2]. Early atherosclerotic changes in the cere-
brovascular system, ultimately leading to incident stroke and
cognitive impairment or dementia [4, 7], could be mirrored
by hypertensive target organ damage in the cardiac, renal,
retinal, and vascular and other systems. Therefore, assess-
ment of hypertensive target organ damage in these systems
may be indicative of the extent of vascular disease in less
easily accessible sites such as the brain.
2.CerebralWML, LeftVentricular
Hypertrophy, and Geometry
Severalformsofheartdamage,suchasheartfailure,coronary
heart disease, and cardiac arrhythmias have been associated
withWML[10]althoughtheunderlyingpathogeneticmech-
anisms are not clear. Studies have reported that echocardio-
graphically determined left ventricularhypertrophy (LVH)is
an independent risk factor for cardiovascular morbidity and
mortality in essential hypertensive patients [18, 19]. Bikkina
etal. [20]demonstrated thatleft ventricularmass (LVM) was
associated with an increased risk of cerebrovascular events
such as stroke and transient ischemic attack in an elderly
cohort from the Framingham Heart Study. It is suggested
that left ventricular geometric patterns add prognostic
information on the development of cardiovascular disease
[21] and the presence of extracardiac target organ damage in
essential hypertension [22, 23]. Hypertensive patients with
concentric LVH have more-advanced target organ damage,
including renal [22, 23] and retinal [23]i n v o l v e m e n t ,t h a n
patients with other patterns of left ventricular geometry.
Some studies have found an association between LVH and
cerebral WML [23–28], butothershave not [29]. We found a
close relationship between silent WML and concentric LVH
in middle-aged untreated essential hypertensive patients,
with WML being more common among patients with
concentric LVH [27]. This association was independent of
thedegree ofBPelevation.The mechanisms connecting LVH
and cerebrovascular damage are unclear and might reﬂect
long-term exposure to genetic, hormonal, or metabolic
factors in addition to BP [30]. It is diﬃcult to diﬀerentiate
the relative role of high BP from the direct contribution
of LVH to the increased risk of cerebrovascular disorders,
and longitudinalstudies are necessary. However, detectionof
cardiac hypertrophy may help to identify patients at risk of
cerebrovascular injury [2].
3.CerebralWML andEarlyRenalAlteration
The brain and the kidney are highly vascular structures that
respond to diseases such as hypertension and diabetes melli-
tus in similar ways at the microscopic level. In nephrosclero-
sis, gradual alterations in the renal endothelial cells, glom-
eruli, and interstitial spaces lead to glomerular leakage of
serum proteins into the urine. If a similar process were
occurring at the endothelial level in cerebral microvessels,
serum proteins would pass into the cerebral extracellular
space. Neuropathological studies show that white matter
hyperintensities may represent enlarged perivascular spaces
and perivascular demyelination, among other mechanisms
[31]. These changes are what might be expected if the cere-
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proteins which, in healthy individuals, should remain within
the vascular space. While there is no direct proof that this
process occurs, some studies have shown that WMLs are
associated with microalbuminuria [32–34].
It has been suggested that the brain and the kidney have
a common, unique way of reacting to ﬂuctuations in BP and
ﬂow due to similar low-resistance vascular beds. High-pres-
sure ﬂuctuations in the carotid, vertebral, and renal arteries,
together with the turbulent ﬂow, expose the small vessels
of these two organs to pressure and ﬂow ﬂuctuations that
may explain the microvascular damage and the resulting
renal failure and neurological and cognitive alterations [35].
In addition, chronic renal disease (CRD) has been linked
with proinﬂammatory and procoagulant states [36], which
may contribute to WML [37, 38]. Therefore, information on
renal microvascular damage may provide information on
cerebral damage. Small vessel disease is a systemic condition
which is induced by aging and exacerbated by vascular risk
factors, especially hypertension, and aﬀects the brain and
other systems.
In the kidney, the damage markers are albuminuria/pro-
teinuria and the estimated glomerular ﬁltration rate (eGFR),
whichshowsthefunctionalreduction.Khatri etal.[39]stud-
ied 615 stroke-free subjects (mean age: 70 years) and found
that the prevalence of silent WML was independently asso-
ciated with CRD (people with eGFR between 15–60mL/min
per 1.73m2 when compared to people with 60–90mL/min,
and >90mL/min) even after adjustment for age, sex, ethnic-
ity, education, and vascular risk factors [24]. The Rotterdam
study [40] of 484 subjects (mean age: 73.4 years; mean sys-
tolic BP: 145.7mmHg; mean eGFR: 54.8mL/min/1.73m2)
found that individuals with a lower eGFR had more WML.
Takahashi et al. [41]recentlystudied2,103asymptomatic
individuals with a younger mean age of 56 years and found
that the prevalence of subcortical WML and periventricular
WML correlated signiﬁcantly with lower eGFR; in sub-
groups with eGFR ≥90, 60–89, and <60mL/min/1.73m2,
respectively, the prevalences were subcortical WML: 18%,
21%, and 37%, respectively; and periventricular WML: 7%,
10%, and 21%, respectively. Mean age diﬀered signiﬁcantly
between groups (mean 51, 55, 63 years, resp.), and BP ≥
130/85mmHgwassigniﬁcantlymoreprevalentaseGFRrose.
Wada et al. [33], in a study of 625 Japanese individuals
aged >61 years, found that subjects with lower eGFR had
highergradesofsilent WML,thatmean gradesofWML were
greater in subjects with albuminuria than in those without,
and that age and the prevalence of hypertension were sig-
niﬁcantly higher in individuals with higher grades of WML.
Knopman et al. [32] also found an independent association
betweenmicroalbuminuria andWML in1251asymptomatic
individuals (mean age: 63.8 years, 78% with hypertension).
4.CerebralWML and Retinal
Microvascular Abnormalities
The retina oﬀers a unique, noninvasive, and easily accessible
window to study the microvascular etiology of cerebrovas-
cular disease. Retinal and cerebral small vessels share similar
embryological origins, anatomical features, and physiologi-
cal properties [42].
Retinal microvascular abnormalities, such as microa-
neurysms, retinal hemorrhages, soft and hard exudates,
arteriovenous nicking,and retinal focalarteriolar narrowing,
usually result from small-vessel damage due to aging and
high BP [43].
Arteriolar narrowing may be a sign of hypertension, a
history of hypertension in the last three to six years, or a
risk factor for the onset of hypertension in normotensive
individuals [44].Large prospective studies(theARIC,Beaver
Dam, Blue Mountains Eye, and Rotterdam studies) have
foundthatreducedarteriolardiameterisanindependentrisk
factor for developing hypertension within 3 to 10 years in
normotensive individuals [43].
Studies have shown that retinal microvascular ﬂow is
reduced in persons with WML and lacunar infarction [45]
and that retinal and cerebral arterioles share a similar histo-
pathology in patients dying from stroke [46]. In the ARIC
study, retinal abnormalities were associated with concurrent
BP [47]. In a cohort of 1684 asymptomatic people aged 51–
72 years from the ARIC study, individuals with WML were
more likely to have retinal microvascular abnormalities [48].
In general, in this study, WMLs were signiﬁcantly associated
with increasing age, black ethnicity, and—after adjusting for
age,sex,andethnicity—withhigherBPandincreasedcarotid
intima-media thickness(IMT).Retinopathywassigniﬁcantly
associated with black ethnicity and, after similar adjustment,
with higher systolic BP, fasting glucose level, diabetes mel-
litus, and increased carotid IMT [48]. After a follow-up of
10 years, retinal microvascular abnormalities measured at
baseline were prospectively associated with a long-term risk
of subclinical cerebrovascular disease on MRI, independent
of conventional risk factors in this population-based cohort
of middle-aged persons without clinical stroke [49]. The
authors suggested that retinal microvascular abnormalities
are early and, possibly, more sensitive markers of subclinical
cerebral small-vessel disease before radiological and clinical
manifestations become apparent. In a cohort of 1717 people
from the Cardiovascular Health Study [50] (mean age: 78.3
years; hypertension: 56.3%; diabetes mellitus: 13%; previous
cardiovascular disease, including stroke: 23.8%) associations
were found between WML grade, prevalent lacunar infarct,
and a lower arteriovenous ratio. In 174 patients without a
history of transient ischemic attack or stroke before follow-
up, WMLs worsening on MRI 5 years later and incident
lacunar infarct were associated with a lower arteriovenous
ratio [50].
In light of data reporting that persons with a smaller ar-
teriolar-to-venular ratio tended to have more WMLs on
MRI, the Rotterdam study evaluated whether this could be
due to arteriolar narrowing or venular dilatation [51]. In a
population-based cohort study of 490 people without de-
mentia (age 60–90 years; mean age: 68.4 years; mean systolic
BP: 136.7 ± 19.9mmHg; diabetic patients: 6.3%), cerebral
small vessel disease was evaluated at baseline. A mean of 3.3
years later, 279 persons had a second MRI. Lacunar infarcts
and WML at baseline, and incident infarct and changes in
periventricular and subcortical WML and progression, were4 Journal of Aging Research
evaluated in the follow-up. Neither venular nor arteriolar
diameters were related to the severity of cerebral small vessel
disease. Larger venular diameters were, however, associated
with a marked progression of cerebral small vessel disease
[51]. It has been hypothesized that retinal venular dilatation
occurs in response to retinal hypoxia and venular dilatation
has been also described as one of the earliest changes in dia-
betic retinopathy.
Retinal microcirculation abnormalities, including reti-
nopathy, reduced arteriolar diameter and, increased venular
caliber are widely observed in the general population [43].
The abnormalities observed in retinopathy may reﬂect dis-
orders of the retinal vascular wall, endothelial dysfunction,
and inﬂammation secondary especially to diabetes mellitus,
age, hypertension, obesity, and metabolic disorders. The de-
creased arteriolar diameter signals the presence of hyperten-
sion (current or old) and the risk of hypertension onset.
An increased venular diameter has been associated with
diabetes mellitus, obesity, and metabolic disorders. All these
abnormalities have been associated with WML.
5.CerebralWMLandBloodVessels
Ultrasonographic ﬁndings of increased atherosclerotic pla-
ques and carotid artery IMT are regarded as the subclinical
markers of early atherosclerosis and are associated with non-
modiﬁable and modiﬁable risk factors and the subsequent
risk of neworrecurrent stroke[52].Somestudieshavefound
that the severity of IMT and the presence of plaques in the
carotid arteries are also predictive ofWML[53–56],although
another study in the elderly did not [57]. This association
between large and small vessel disease may well be mediated
via common intermediary risk factors such as hypertension.
It is known that the arterial system gradually stiﬀens due
to the combined eﬀects of aging, high BP, and other vascular
risk factors. Increased arterial stiﬀness results in characteris-
tic increased impedance and pulse wave velocity (PWV) in
the aorta, which increases systolic and pulse pressure (PP)
centrally. Stiﬀ arteries cause high PP and pulsatile ﬂow to
be transmitted to distal organs during systole, damaging
the cerebral microvasculature. It has been hypothesized that
cerebral microvascular disease results from the damaging
forces of abnormal ﬂow pulsations extending into small
cerebral arteries as a consequence of arterial stiﬀening.
In a homogeneous sample of never-treated hypertensive
patients aged 50–60 years, after exclusion for known risk
factors for cerebrovascular damage, such as diabetes mellitus
or signiﬁcant alcohol intake, Sierra et al. [58]f o u n da n
association between higher PP (including oﬃce, ambulatory
24 hours, daytime and nighttime estimates) as a measure of
arterial stiﬀness and WML. In the elderly,ithasrecentlybeen
shown that brachial PP is associated with WML [59].
Laurent et al. [60] found that aortic stiﬀness, assessed by
carotid-femoral PWV using applanation tonometry, thegold
standard for arterial stiﬀness measurement, was an indepen-
dentpredictorof fatal stroke inpatients with essential hyper-
tension. Whether the risk of stroke is mediated by large-
and/or small-vessel disease is not clear, but the previously
reported increased risk of stroke when preclinical cerebral
microvascular disease (WML, silent lacunar infarcts, and/or
cerebral microbleeds) is present suggests small-vessel disease
involvement [4, 7]. Henskens et al. [61] studied 167 hyper-
tensive subjects (mean age: 51.8 years) and found that higher
PWV was signiﬁcantly associated with a greater volume of
WMLandlacunarinfarcts,butnotwithcerebralmicrobleeds
after multivariate analyses adjusted for age, sex, brain
volume, mean BP, and heart rate. This suggests that aortic
stiﬀness is independently associated with the manifestations
of cerebral small-vessel disease in hypertensive patients and
links systemic large- to cerebral small-artery disease. With
respect to radial arterial pulse wave analysis, Shrestha et al.
[62] studied 179 unselected patients with a mean age of 66
years and found that central systolic BP values, measured by
radial applanation tonometry, were more closely associated
with WML than brachial systolic BP. In this study, the
augmentation index did not correlate with the presence of
WML.
6.CerebralWML, Inﬂammation,and
EndothelialFunction
The role of inﬂammation in atherosclerosis and stroke has
received increasing attention as basic and clinical research
has provided evidence that inﬂammatory mechanisms play
a central role in the pathogenesis and progression of ath-
erosclerosis, plaque rupture, thrombosis, and stroke [38].
Endothelial dysfunction contributes to the initiation of ath-
erosclerotic lesions. Whether inﬂammatory processes, apart
from their involvement in large-vessel disease, are also
involved in the development and consequences of cerebral
small-vessel disease is still poorly understood.
Some studies have shown a relationship between WML
and markers of inﬂammation, such as C-reactive protein
[63], while others have not [64, 65]. A similar relationship
has also been found with plasma homocysteine levels [66],
lipoprotein-associated phospholipase A2 (Lp-PLA2), and
myeloperoxidase (MPO) [67]. Plasma markers of endothe-
lial dysfunction such as intercellular adhesion molecule-1
(ICAM-1) and P-selectin have also been associated with
WML[68,69].Ithasrecentlybeensuggestedthatendothelial
activationassociatedwithsmallvesseldiseaseisaccompanied
by enhanced levels of tissue plasminogen activator (tPA)
and low levels of plasminogen activator inhibitor type 1
(PAI-1) when lacunar strokes are associated with WML,
suggesting that diﬀerences in the activity of components of
the ﬁbrinolytic system might contribute to the development
of WML [70].
Inspite of their small simple size one study has reported
that altered vascular function and structure in subcutaneous
small arteries of patients with late-life depression are related
to cerebral small vessel disease, including WML, and basal
ganglia and infratentorial changes [71]. The study was
performed in 16 patients with late-life depression (68.8%
hypertensives) who were compared with 15 controls (80%
hypertensives). Smallarterieswere isolatedand studiedusing
pressure myography after subcutaneous gluteal fat biopsy.Journal of Aging Research 5
In summary, there is some evidence to show that inﬂam-
mation, impaired endothelial function, and abnormal wall
growth are involved in the pathogenesis of WML.
Rizzonietal.[72]foundthatthesmall cerebralarteries of
patients with essential hypertension had an increased media/
lumen ratio compared with normotensive individuals, sim-
ilar ﬁnding to those previously observed in subcutaneous
small arteries. Structural alterations of cerebral small vessels
were assessed in 13 hypertensive patients and 15 normoten-
sive individuals undergoing neurosurgery for benign or
malign tumors. A small portion of morphologically normal
cerebral tissue was excised from surgical samples and exam-
ined, and cerebral small resistance arteries were dissected
and mounted on an isometric and isobaric myograph.
An increased media-to-lumen ratio of subcutaneous small
resistance arteries has also been shown to predict the devel-
opment of cardio-cerebrovascular events in hypertensive
patients [73].
7.Conclusion
Evidence on the prognostic role of subclinical organ damage
continues to grow. Early detection of hypertensive target
organ damage is important in order to prevent cardio-
vascular diseases more successfully and improve patients’
outcomes [1, 2].
After age, hypertension is the most-important factor for
the development of cerebral WML [4, 10], which are an
important prognostic factor for stroke, cognitive impair-
ment, dementia, and death [7]. Various studies have shown
an association between WML and a number of extracranial
systems aﬀected by high BP. There are ﬁndings that suggest
that correct antihypertensive treatment couldeﬃciently slow
WML progression [11–13]. Strong evidence suggests that
cerebral WML in hypertensive patients should be considered
a silent early marker of brain damage.
The latest Reappraisal of the European Guidelines on
hypertension management [2]reports that, inagroup of192
untreated hypertensive patients (aged 18–90 years) without
overt cardiovascular disease, silent cerebrovascular lesions
(WML, lacunar infarcts, cerebral microbleeds) were even
more prevalent (44%) than cardiac (21%) and renal (26%)
subclinical damage and frequently occur in the absence of
other signs of organ damage [5]. Similarly, 58% of patients
with demonstrable cardiac or renal damage or both had
silent cerebrovascular lesions.
With MRI being increasingly used for diagnostic pro-
cedures, investigation of silent cerebrovascular disease will
become more frequent in prognostic and therapeutic studies
in hypertension. In the meantime, target organ damage in
other systems may aid the evaluation of early hypertensive
brain damage.
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